Cephalosporin antibiotic drug product of Hanmi Pharmaceutical enters into the European market for the nation's first time
Cephalosporin antibiotic drug product of Hanmi Pharmaceutical enters into the European market for the nation's first time.
On June 29, Hanmi Pharmaceutical announced that they received final marketing authorization of cephalosporin antibiotic 'Triaxon 1g injection' from the four countries in Eur...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
